Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Ginkgo Bioworks Holdings Inc.
DNA | US
6.99
USD0.28
4.17%
DNA | US
About Ginkgo Bioworks Holdings Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
23/03/2026
Close
6.99
Open
6.92
High
7.01
Low
6.63
Ginkgo Bioworks Holdings Inc. together with its subsidiaries develops platform for cell programming. Its platform is used to program cells to enable biological production of products such as novel therapeutics food ingredients and chemicals derived from petroleum. The company serves various end markets including specialty chemicals agriculture food consumer products and pharmaceuticals. Ginkgo Bioworks Holdings Inc. was founded in 2008 and is headquartered in Boston Massachusetts.
View LessDNA | US
Risk
127.9
Sharpe
-0.08
Luna's Score
34/100
Recommendation
Sell
Luna says (DNA | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
78.7%1 month
127.9%3 months
103.3%6 months
98.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.59
Debt to equity
0.54
Debt to assets
0.28
Ent. to EBITDA
-1.79
Ent. to rev.
1.17
PEG
-
Other Fundamentals
EBITDA
-633.69M
MarketCap
388.47M
MarketCap(USD)
388.47M
Div. yield
-
Op. margin
-274.48
Erngs. growth
-
Rev. growth
-30.20
Ret. on equity
-76.83
Short ratio
4.48
Short perc.
26.25
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.84
Range1M
3.46
Range3M
4.84
Volumes: Market Activity
Rel. volume
0.98
Price X volume
8.28M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.79 | - | Cheaper |
| Ent. to Revenue | 1.17 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.59 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 103.31 | - | Riskier |
| Debt to Equity | 0.54 | -1.23 | Expensive |
| Debt to Assets | 0.28 | 0.25 | Par |
| Market Cap | 388.47M | - | Emerging |
